Gene · 26
Papers3,157
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
941 to 960 of 3,157
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Effects of permissive hypocaloric vs standard enteral feeding on gastrointestinal function and outcomes in sepsis. | World J Gastroenterol | 2021 | 34447234 | PubTator, text mining | PubMed |
| The Effect of Type-I Photoinitiators on the Kinetics of the UV-Induced Cotelomerization Process of Acrylate Monomers and Properties of Obtained Pressure-Sensitive Adhesives. | Materials (Basel) | 2021 | 34443085 | PubTator, text mining | PubMed |
| Proanthocyanidins and Where to Find Them: A Meta-Analytic Approach to Investigate Their Chemistry, Biosynthesis, Distribution, and Effect on Human Health. | Antioxidants (Basel) | 2021 | 34439477 | PubTator, text mining | PubMed |
| DUSP7 inhibits cervical cancer progression by inactivating the RAS pathway. | J Cell Mol Med | 2021 | 34435746 | PubTator, text mining | PubMed |
| Insights Into the Structure-Function Relationships of Dimeric C3d Fragments. | Front Immunol | 2021 | 34434196 | PubTator, text mining | PubMed |
| Reconstitution and Structural Analysis of a HECT Ligase-Ubiquitin Complex via an Activity-Based Probe. | ACS Chem Biol | 2021 | 34403242 | PubTator, text mining | PubMed |
| Design, Synthesis, and Biological Evaluation of Stable Colchicine-Binding Site Tubulin Inhibitors 6-Aryl-2-benzoyl-pyridines as Potential Anticancer Agents. | J Med Chem | 2021 | 34378386 | PubTator, text mining | PubMed |
| Histamine signaling and metabolism identify potential biomarkers and therapies for lymphangioleiomyomatosis. | EMBO Mol Med | 2021 | 34378323 | PubTator, text mining | PubMed |
A Pilot Study Evaluating the Effectiveness and Safety of Daikenchuto (TJ-100) for the Treatment of Postoperative Abdominal Pain or Bloating in Patients Undergoing Hepatectomy: Study Protocol for a Randomized, Open, Controlled Trial. | Kurume Med J | 2021 | 34373384 | PubTator, text mining | PubMed |
| Psychological and Gastrointestinal Symptoms of Patients with Irritable Bowel Syndrome Undergoing a Low-FODMAP Diet: The Role of the Intestinal Barrier. | Nutrients | 2021 | 34371976 | PubTator, text mining | PubMed |
| Intestinal congestion and reperfusion injury: damage caused to the intestinal tract and distal organs. | Biosci Rep | 2021 | 34369557 | PubTator, text mining | PubMed |
| Origin, Succession, and Control of Biotoxin in Wine. | Front Microbiol | 2021 | 34367103 | PubTator, text mining | PubMed |
| Supplemental bifid triple viable capsule treatment improves inflammatory response and T cell frequency in ulcerative colitis patients. | BMC Gastroenterol | 2021 | 34348654 | PubTator, text mining | PubMed |
| Active bath-induced localization and collapse of passive semiflexible polymers. | J Chem Phys | 2021 | 34340385 | PubTator, text mining | PubMed |
| Protective influence of betaine on intestinal health by regulating inflammation and improving barrier function in broilers under heat stress. | Poult Sci | 2021 | 34329984 | PubTator, text mining | PubMed |
| Diverse expression patterns of mucin 2 in colorectal cancer indicates its mechanism related to the intestinal mucosal barrier. | World J Gastroenterol | 2021 | 34321852 | PubTator, text mining | PubMed |
| Effects of tea polyphenols on the activities of antioxidant enzymes and the expression of related gene in the leaves of wheat seedlings under salt stress. | Environ Sci Pollut Res Int | 2021 | 34319523 | PubTator, text mining | PubMed |
| Amine oxidase, copper containing 3 exerts anti‑mesenchymal transformation and enhances CD4+ T‑cell recruitment to prolong survival in lung cancer. | Oncol Rep | 2021 | 34318901 | PubTator, text mining | PubMed |
| Therapeutic targets, novel drugs, and delivery systems for diabetes associated NAFLD and liver fibrosis. | Adv Drug Deliv Rev | 2021 | 34314787 | PubTator, text mining | PubMed |
| Small intestinal bacterial overgrowth and evaluation of intestinal barrier function in patients with ulcerative colitis. | Am J Transl Res | 2021 | 34306403 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/26/papers?page=48